Shares Outstanding (Quarterly) Chart

Historical Shares Outstanding (Quarterly) Data

View and export this data back to 1998. Start Trial.
Date Value
June 30, 2026 37.70M
March 31, 2026 37.48M
May 31, 2025 37.03M
February 28, 2025 37.03M
November 30, 2024 36.98M
August 31, 2024 30.90M
May 31, 2024 30.56M
February 29, 2024 30.55M
November 30, 2023 30.46M
August 31, 2023 30.46M
May 31, 2023 30.32M
February 28, 2023 30.32M
November 30, 2022 30.30M
August 31, 2022 29.59M
May 31, 2022 29.51M
February 28, 2022 29.48M
November 30, 2021 29.48M
August 31, 2021 29.46M
May 31, 2021 29.33M
February 28, 2021 29.32M
November 30, 2020 29.32M
August 31, 2020 29.24M
May 31, 2020 29.10M
February 29, 2020 29.18M
November 30, 2019 29.16M
Date Value
August 31, 2019 29.15M
May 31, 2019 29.10M
February 28, 2019 29.01M
November 30, 2018 27.78M
August 31, 2018 27.75M
May 31, 2018 27.70M
February 28, 2018 27.56M
November 30, 2017 27.53M
August 31, 2017 27.51M
May 31, 2017 27.50M
February 28, 2017 27.30M
November 30, 2016 27.26M
August 31, 2016 27.24M
May 31, 2016 27.15M
February 29, 2016 27.07M
November 30, 2015 27.03M
August 31, 2015 27.02M
May 31, 2015 26.99M
February 28, 2015 26.90M
November 30, 2014 26.88M
August 31, 2014 26.85M
May 31, 2014 26.82M
February 28, 2014 26.78M
November 30, 2013 26.65M
August 31, 2013 26.48M

Shares Outstanding Definition

The volume of stock shares issued by the company and in the hands of the public. This number entails how much is being traded in the open market. A decreasing shares outstanding over time may be the result of company buybacks. Companies frequently make stock buybacks and retire those buybacks as treasury stock.

Read full definition.

Shares Outstanding (Quarterly) Range, Past 5 Years

View Shares Outstanding (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Shares Outstanding (Quarterly) Benchmarks

View Shares Outstanding (Quarterly) Benchmarks
Start Trial
Codexis, Inc. 91.39M
Quanterix Corp. 47.14M
Frontage Holdings Corp. --
Repligen Corp. 56.43M
Bio-Techne Corp. 156.10M